World News Roundup: Sleeping with lights or TV on tied to obesity; U.S. measles outbreak spreads

Following is a summary of current health news briefs.

Roche's combo lymphoma treatment wins FDA's accelerated approval

The U.S. Food and Drug Administration granted accelerated approval to Roche Holding AG's combo lymphoma treatment for previously treated patients, the company said on Monday. The drug, Polivy, is used in combination with Rituxan and a chemotherapy agent to treat an aggressive form of the disease.

Abbott device helps in cutting blood sugar in type 2 diabetics: study

(The June 8 story corrects first paragraph to clarify that the study compared patients with type 2 diabetes before and after using Abbott's device; In paragraph 4, clarifies that the patients used insulin injections every day over an average of more than 8 years.) Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc's continuous glucose monitoring system for three months compared with when they were not using the device, researchers said on Saturday.

Sleeping with lights or TV on tied to obesity

For middle-aged and older women, sleeping with the television or lights on has been linked with higher odds of becoming obese, in a recent U.S. study. While a high-calorie diet and sedentary behavior are the most commonly cited explanations for obesity, some previous research has also linked exposure to artificial light at night to an increased risk of weight gain, researchers note in JAMA Internal Medicine.

China to tighten rules on foreigners using genetic material

China said on Monday it will tighten regulations on human genetic material, putting checks on the passing of it abroad and insisting that any foreign companies or institutes wanting to use it in their work do so with a Chinese partner. The cabinet, the State Council, said the new regulations would take effect from July 1, and were aimed at promoting the proper use of such material, ranging from DNA to human organs, blood and tissue.

Patients give more '5-star' ratings to hospitals with fewer services

Compared to smaller facilities, hospitals that provide complex care for critical illness or serious injury may find it harder to make patients happy, a U.S. study suggests. Patients may be more likely to give top '5-star' ratings to hospitals that don't offer many commonly sought-after services like emergency rooms and intensive care units, the study found.

U.S. measles outbreak spreads to Idaho and Virginia, hits 1,022 cases

The United States' worst measles outbreak in a quarter-century spread to Idaho and Virginia last week as public health authorities on Monday reported 41 new cases of the highly contagious and sometimes deadly disease. The U.S. has recorded 1,022 cases of the diseases this year as of June 6, in an outbreak blamed on misinformation about vaccines, the U.S. Centers for Disease Control and Prevention said.

Experimental drug delays type 1 diabetes onset in mid-stage trial

In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday. The 76 study participants, who ranged in age from 8 to 49, faced a high risk of type 1 diabetes in part because their relatives had the autoimmune disease, which kills the beta cells in the pancreas that make and release insulin. Also, the volunteers all had tests showing diabetes-related autoantibodies that attack the pancreas, plus unhealthy blood sugar levels.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)